Like a first date for those seeking significant others in the realm of clinical research, the site qualification visit (SQV) by a monitor representing a potential study sponsor or contract research organization can make or break a relationship, says Lisa Ince, CCRC, CCRA, FACRP, a Project Manager I in oncology trials with the Clinical Solutions division of Syneos Health.
The ability to move from intentions to actions in support of diversity, equity, and inclusion in clinical research is vital to opening more trials to underrepresented populations, and formulating a diversity action plan according to regulatory guidance is key to the process.